“Pancreatic+cancer”的搜索结果，显示 51-60 项，共有 7723 项

1. 神经科- 临床试验- 妙佑医疗国际

   ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

2. 胰腺神经内分泌肿瘤- 症状与病因- 妙佑医疗国际

   Neuroendocrine tumor of the pancreas. Cancer.Net. https://www.cancer.net/cancer-types/islet-cell-tumor/view-all. Accessed Feb. 27, 2023. NPF Centers of ...

3. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers. Rochester, Minn. A Phase 1b/2, open label, multi ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The Early Detection Initiative for pancreatic cancer is a multi-center randomized controlled trial to determine if algorithm-based screening in patients with ...

6. 神经科- 临床试验- 妙佑医疗国际

   ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

8. 神经科- 临床试验- 妙佑医疗国际

   ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

9. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers. Rochester, Minn. A Phase 1b/2, open label, multi ...

10. 惠普尔手术- 妙佑医疗国际

    Long-term pancreatic cancer survivors report excellent post-surgery quality of life Aug. 28, 2023, 01:30 p.m. CDT; Mayo Clinic Q and A: What is ...